OTC · Consumer staples

COSCIENS Biopharma Inc. (CSCID)

COSCIENS Biopharma Inc. reported revenue of $7.5M in fiscal 2025, down 21.8% from a year earlier. It posted a net loss of $10.4M. In fiscal 2025 capital spending exceeded operating cash flow by $9.2M. At December 31, 2025 it held $7.3M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 25, 2026.

Watch CSCID in 60 seconds

Price

$5.14

0.00% on the day · August 11, 2026

52-week range $2.37 to $10.53

Revenue (FY2025)

$7.5M

-21.8% year on year

Net margin

-138.1%

What COSCIENS Biopharma Inc. does

COSCIENS Biopharma Inc. is registered with the SEC under industry code SIC 2844 (Perfumes, Cosmetics & Other Toilet Preparations). Its shares trade on OTC under the ticker CSCID.

Revenue and profit by year

Revenue

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	$7.5M	-$10.7M	-$10.4M	-$3.27	-$9.2M
2024	$9.6M	-$18.3M	-$15.3M	-$5.93	-$15.7M
2023	$7.1M	-$4.6M	-$3.5M	-$1.89	-$3.3M
2022	$14.6M	$4.3M	$3.4M	$1.86	$4.9M
2021	$5.3M	-$8.7M	-$8.4M	-$1.01	-$8.6M
2020	$3.7M	-$5.7M	-$5.1M	-$1.72	n/a

Full financial statements: income, balance sheet and cash flow

Where CSCID ranks in Consumer staples

Revenue$7.5M

#131 of 154 in Consumer staples · Bottom 15%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Consumer staples

Latest SEC filings

What COSCIENS Biopharma Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

July 6, 2026
Deregistration 15-12G
July 6, 2026
Form SC 13E3/A filing SC 13E3/A
July 6, 2026
Foreign issuer update 6-K
June 23, 2026
Form SC 13E3/A filing SC 13E3/A
June 23, 2026
Foreign issuer update 6-K
June 18, 2026
Foreign issuer update 6-K
June 18, 2026
Form SC 13E3/A filing SC 13E3/A
May 20, 2026
Form SC 13E3/A filing SC 13E3/A
May 20, 2026
Foreign issuer update 6-K
May 12, 2026
Form SC 13E3/A filing SC 13E3/A

All filings on SEC EDGAR

Questions about CSCID

What does COSCIENS Biopharma Inc. do?

COSCIENS Biopharma Inc. is registered with the SEC under industry code SIC 2844 (Perfumes, Cosmetics & Other Toilet Preparations). Its shares trade on OTC under the ticker CSCID.

Is COSCIENS Biopharma Inc. profitable?

No. In fiscal 2025 it reported a net loss of $10.4M on revenue of $7.5M.

How much revenue does COSCIENS Biopharma Inc. make?

In fiscal 2025 COSCIENS Biopharma Inc. reported revenue of $7.5M. That is 21.8% less than a year earlier.

When did COSCIENS Biopharma Inc. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 25, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the deregistration from July 6, 2026.

Similar companies

Colgate Palmolive Co

KVUE

Kenvue Inc.

Estee Lauder Companies Inc

EDGEWELL PERSONAL CARE Co

Compare CSCID with

Compare CSCID with any company

Follow CSCID

Get an email when COSCIENS Biopharma Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow CSCID: get an email when it files

Where the numbers come from

Financial figures are the values COSCIENS Biopharma Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.